This case study shares insights from engineers at Abbott Technologies on … [Read More...]
White Papers
ePTFE for the Cardiovascular Device Industry
For over 35 years, ePTFE has been a mainstay of the cardiovascular device … [Read More...]
Sponsored Content
Quick Launch Program for Micro Medical Production
By Lindsay Mann, Director of Sales & Marketing For OEMs who need a rapid prototype of their new medical device design, there are plenty of vendors to choose from. But for OEMs who are ready to … [Read More...]
Connecting the Next Generation of Medical Data and Devices to Improve Patient Outcomes
Every day, hospitals and doctors collect infinite amounts of data on individual patients, diseases and medical procedures. The rise of a new generation of robotic, precision, and surgical devices has … [Read More...]
Outcome-based Pricing Initiatives in the Healthcare Industry
By Joe Miles - Global Vice President, Life Sciences (SAP Industries) and Bob Steller - Industry Principle, Life Sciences (Vistex) A distorted reimbursement model has driven healthcare costs ever … [Read More...]
Mergers & Acquisitions.
3M funds Acelity buyout with $3.3B debt offering
3M (NYSE:MMM) is planning to finance its $6.7 billion acquisition of Acelity in part with a $3.3 billion debt offering. Maplewood, Minn.-based 3M, which announced its purchase of wound care giant Acelity in May, launched a four-part bond sale yesterday. 3M expects to finance the Acelity buyout with all of the net proceeds from the […]
Boston Scientific closes $4B BTG purchase
Boston Scientific (NYSE:BSX) said today that it finished its $4 billion acquisition of BTG (LN:BTG). The Marlborough, Mass.-based medtech giant reported that the transaction will be immaterial to adjusted earnings per share this year, thanks to – among other factors – the deal closing later than initially anticipated. To satisfy antitrust regulators, Boston Scientific is […]
UK regulators OK Boston Scientific’s $4B BTG buyout
British regulators have approved Boston Scientific’s (NYSE:BSX) $4 billion bid to buy BTG (LN:BTG), the companies announced today in regulatory filings. The deal, approved by the U.S. Federal Trade Commission on August 7, will close on Monday. The High Court of Justice in England and Wales agreed to the takeover following a hearing today. Boston […]
UK antitrust regulators probe Kohlberg’s Nelipak-Bemis merger
Antitrust regulators in the U.K. yesterday opened a probe into the planned merger of Nelipak and Bemis Healthcare Packaging Europe by private equity shop Kohlberg. The PE giant acquired Cranston, R.I.-based Nelipak, which manufactures rigid healthcare packaging used in Class II and Class III medical devices and pharma drug-delivery products, in early July for an undisclosed amount. Get […]
AtriCure closes $300m SentreHeart buyout
AtriCure (NSDQ:ATRC) said yesterday that it closed the $300 million buyout of SentreHeart and its Lariat left atrial appendage closure device. The offer included $40 million in up-front cash and stock, plus $140 million in clinical and regulatory milestones and $120 million in reimbursement milestones, all payable in cash and stock, Mason, Ohio-based AtriCure said when the […]
Stryker puts up $52m for TSO3
Stryker (NYSE:SYK) today agreed to pay $52 million to acquire TSO3 (TSX:TOS) and its Sterizone VP4 sterilizer. The C43¢-per-share offer works out to about C$68.4 million ($51.7 million), representing an 18% premium on the 30-day volume-weighted average share price, Quebec City-based TSO3 said. “TSO3‘s board of directors and management believe that this transaction provides the best […]
AtriCure offers $300m for SentreHeart
AtriCure (NSDQ:ATRC) said today that it put up a $300 million offer for SentreHeart and its Lariat left atrial appendage closure device. Redwood City, Calif.-based SentreHeart has enrolled 535 patients in the Amaze trial comparing Lariat and pulmonary vein isolation with PVI alone in treating atrial fibrillation. Today AtriCure said it expects the study tor each […]
MassDevice Network
@MassDevice
LinkedIn
YouTube